EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Phenotype Correlations With Pathogenic DNA Variants in the MUTYH Gene: A Review of Over 2000 Cases

Monica Thet iD, John-Paul Plazzer iD, Gabriel Capella iD, Andrew Latchford iD, Emily A W Nadeau iD, Marc S Greenblatt iD, Finlay Macrae iD

Human Mutation · 2024

DOI: 10.1155/2024/8520275 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Human Mutation, 2024. Verfasst von Monica Thet und 6 weiteren Autor:innen. Beteiligte Einrichtung: Melbourne Medical School The University of Melbourne, Parkville, Victoria, Australia. Hauptthemen laut MEDLINE: DNA Glycosylases, Adenomatous Polyposis Coli, Genetic Association Studies, Mutation. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 69 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, Instituto de Salud Carlos III, Agencia Estatal de Investigación.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

MUTYH ‐associated polyposis (MAP) is an autosomal recessive disorder where the inheritance of constitutional biallelic pathogenic MUTYH variants predisposes a person to the development of adenomas and colorectal cancer (CRC). It is also associated with extracolonic and extraintestinal manifestations that may overlap with the phenotype of familial adenomatous polyposis (FAP). Currently, there are discrepancies in the literature regarding whether certain phenotypes are truly associated with MAP. This narrative review is aimed at exploring the phenotypic spectrum of MAP to better characterize the MAP phenotype. Literature search was conducted to identify articles reporting on MAP‐specific phenotypes. Clinical data from 2109 MAP patients identified from the literature showed that 1123 patients (53.2%) had CRC. Some patients with CRC had no associated adenomas, suggesting that adenomas are not an obligatory component of MAP. Carriers of the two missense founder variants, and possibly truncating variants, had an increased cancer risk when compared to those who carry other pathogenic variants. It has been suggested that somatic G:C > T:A transversions are a mutational signature of MAP and could be used as a biomarker in screening and identifying patients with atypical MAP, or in associating certain phenotypes with MAP. The extracolonic and extraintestinal manifestations that have been associated with MAP include duodenal adenomas, duodenal cancer, fundic gland polyps, gastric cancer, ovarian cancer, bladder cancer, and skin cancer. The association of breast cancer and endometrial cancer with MAP remains disputed. Desmoid tumors and congenital hypertrophy of the retinal pigment epithelium (CHRPEs) are rarely reported in MAP but have long been seen in FAP patients and thus could act as a distinguishing feature between the two. This collection of MAP phenotypes will assist in the assessment of pathogenic MUTYH variants using the American College of Medical Genetics and the Association for Molecular Pathology (ACMG/AMP) Variant Interpretation Guidelines and ultimately improve patient care.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DNA GlycosylasesAdenomatous Polyposis ColiGenetic Association StudiesMutationHumansPhenotypeGenetic Predisposition to DiseaseColorectal Neoplasms

Substanzen

mutY adenine glycosylaseDNA Glycosylases

Autor:innen und Institutionen

  • Melbourne Medical School The University of Melbourne, Parkville, Victoria, Australia.
  • Department of Medicine University of Melbourne Royal Melbourne Hospital, Parkville, Australia.
  • Department of Colorectal Medicine and Genetics Royal Melbourne Hospital, Parkville, Australia.
  • Hereditary Cancer Program Catalan Institute of Oncology IDIBELL Hospitalet de Llobregat, Barcelona, Spain.
  • Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain.
  • Polyposis Registry St Mark's Hospital, Harrow, UK.

ORCID-Profile: Monica Thet, John-Paul Plazzer, Gabriel Capella, Andrew Latchford, Emily A W Nadeau, Marc S Greenblatt, Finlay Macrae

Förderung

  • NCI NIH HHS
  • Instituto de Salud Carlos III
  • Agencia Estatal de Investigación
  • Ministerio de Ciencia e Innovación
  • National Institutes of Health
  • University of Melbourne

Zitieren

APA

Thet, M., Plazzer, J. P., Capella, G., Latchford, A., Nadeau, E. A. W., Greenblatt, M. S., & Macrae, F. (2024). Phenotype Correlations With Pathogenic DNA Variants in the MUTYH Gene: A Review of Over 2000 Cases. Human Mutation. https://doi.org/10.1155/2024/8520275

Vancouver

Thet M, Plazzer JP, Capella G, Latchford A, Nadeau EAW, Greenblatt MS, et al. Phenotype Correlations With Pathogenic DNA Variants in the MUTYH Gene: A Review of Over 2000 Cases. Human Mutation. 2024. doi:10.1155/2024/8520275

BibTeX
@article{Thet2024,
  author = {Thet, Monica and Plazzer, John-Paul and Capella, Gabriel and Latchford, Andrew and Nadeau, Emily A W and Greenblatt, Marc S and Macrae, Finlay},
  title = {Phenotype Correlations With Pathogenic DNA Variants in the MUTYH Gene: A Review of Over 2000 Cases},
  journal = {Human Mutation},
  year = {2024},
  doi = {10.1155/2024/8520275}
}
Kostenlos starten →